1 study found for:    20688393 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: ara-C;   Biological: gemtuzumab ozogamicin

Indicates status has not been verified in more than two years